Merck | MRK

Stock Price
130.49
Daily Change
3.59 2.83%
Monthly
3.96%
Yearly
15.04%
Q2 Forecast
129.43
Peers Price Chg Day Year Date
ABBV AbbVie 167.20 -0.81 -0.48% 3.34% Apr/25
ABT Abbott 106.90 -0.06 -0.06% -1.70% Apr/25
ALKS ALKERMES 24.44 0.37 1.52% -13.90% Apr/25
AMGN Amgen 269.42 -3.72 -1.36% 12.82% Apr/25
AZN AstraZeneca 12,007.00 -19.00 -0.16% 1.79% Apr/26
BIIB Biogen 202.49 0.36 0.18% -29.70% Apr/25
BMY Bristol-Myers Squibb 44.70 -4.16 -8.51% -34.28% Apr/25
CTLT Catalent 55.80 -0.14 -0.25% 31.73% Apr/25
GILD Gilead Sciences 65.07 -1.83 -2.73% -22.30% Apr/25
GSK GlaxoSmithKline 1,639.00 -1.50 -0.09% 14.06% Apr/26
GSK Glaxosmithkline 40.91 0.05 0.12% 13.86% Apr/25
JNJ J&J 146.84 -1.73 -1.16% -9.70% Apr/25
LLY Eli Lilly 729.01 -8.11 -1.11% 93.75% Apr/25
MDT Medtronic 79.06 -1.21 -1.50% -12.13% Apr/25
MRK Merck 130.49 3.59 2.83% 15.04% Apr/25
NOVN Novartis 89.48 -0.52 -0.58% -2.05% Apr/26
NVS Novartis 99.12 0.74 0.75% -3.34% Apr/25
PBH Prestige Brands 70.14 0.01 0.01% 14.81% Apr/25
PCRX Pacira 25.50 -0.40 -1.54% -42.14% Apr/25
PFE Pfizer 25.26 -0.97 -3.69% -34.61% Apr/25
PRGO Perrigo 31.26 0.03 0.10% -13.28% Apr/25
RDY Drreddys Laboratories 74.02 3.10 4.37% 24.47% Apr/25
REGN Regeneron Pharmaceuticals 906.54 -16.99 -1.87% 16.52% Apr/25
ROG Roche Holding 219.50 0.70 0.32% -20.53% Apr/26
SAN Sanofi 90.12 -1.51 -1.64% -11.50% Apr/26
SNY Sanofi 49.33 2.77 5.95% -12.26% Apr/25
UTHR United Therapeutics 235.98 -1.02 -0.43% 4.48% Apr/25
ZTS Zoetis 153.44 2.51 1.66% -11.28% Apr/25

Indexes Price Day Year Date
SPX US500 5083 -23.21 -0.46% 22.90% Apr/26
INDU US30 38143 -375.12 -0.98% 12.76% Apr/26

Merck & Co traded at $130.49 this Thursday April 25th, increasing $3.59 or 2.83 percent since the previous trading session. Looking back, over the last four weeks, Merck gained 3.96 percent. Over the last 12 months, its price rose by 15.04 percent. Looking ahead, we forecast Merck & Co to be priced at 129.43 by the end of this quarter and at 122.15 in one year, according to Trading Economics global macro models projections and analysts expectations.

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.